Literature DB >> 30225486

Influence of the substituent on the phosphine ligand in novel rhenium(i) aldehydes. Synthesis, computational studies and first insights into the antiproliferative activity.

Michelle Muñoz-Osses1, Daniel Siegmund, Alejandra Gómez, Fernando Godoy, Angélica Fierro, Leonel Llanos, Daniel Aravena, Nils Metzler-Nolte.   

Abstract

Cyrhetrenyl aldehyde derivatives [(η5-C5H4CHO)Re(CO)2PR3] with R = methyl (Me, 2a), phenyl (Ph, 2b), and cyclohexyl (Cy, 2c) were synthesized by a photochemical reaction from the starting material [(η5-C5H4CHO)Re(CO)3] (1) and the corresponding phosphines. The complexes were fully characterized by FT-IR, 1H, 13C and 31P NMR spectroscopy, elemental analysis and mass spectrometry. The molecular structures of 2a-c have also been determined. Electronic structure calculations by TD-DFT and electrochemical studies are in sound agreement with the effect of the substitution of one carbonyl group by a phosphine ligand. Additionally, the antiproliferative activity of complexes 1 and 2a-c was studied on the human cancer cell lines HT-29 and PT-45 using an MTT assay. Out of all new compounds, only the triphenylphosphine derivative 2b exhibited pronounced cytotoxic effects on both cell lines, being ca. 1.5 times more potent than cisplatin.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30225486     DOI: 10.1039/c8dt03160f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

Review 1.  Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs.

Authors:  Ajay Sharma S; Vaibhavi N; Binoy Kar; Utpal Das; Priyankar Paira
Journal:  RSC Adv       Date:  2022-07-14       Impact factor: 4.036

Review 2.  Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives.

Authors:  Kevin Schindler; Fabio Zobi
Journal:  Molecules       Date:  2022-01-15       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.